• Experic

  Led · Series B · Nov 2022

  Experic provides CDMO and clinical trial supply services with capabilities across packaging and finished-dose modalities, including dry powder inhalation (DPI) products. The company operates a state-of-the-art cGMP facility and emphasizes handling of low-dose powders and customer-oriented, white-glove service. Experic offers end-to-end development and manufacturing services intended to accelerate development and commercialization of therapies. The firm said new growth capital will enable enhancement of its manufacturing capabilities and support accelerated international expansion. Management framed the funding as a way to meet growing demand from biopharma customers and to expand technical capabilities. The company is based in Cranbury, N.J., and delivers global clinical trial supply and manufacturing services. Experic provides formulation, development, manufacturing, and analytical services for hard-to-handle powder drug products as well as clinical trial supply and logistics. The company supports every phase of a product’s life cycle from conception to clinical and commercial scale across dosing and packaging formats including tablets, pellets, capsules, and low-dose dry powder inhalation. Experic operates a state-of-the-art Class A cGMP facility in Cranbury, New Jersey. Over the past year it has experienced extraordinary growth in demand for its services. The company emphasizes personalized service and a flexible approach that drives repeat business. Recent capital will be used to expand capabilities, grow the Cranbury facility, hire top talent, and make further capital investments.

• CI Security

  Led · Series B · Apr 2019

  CI Security is a Seattle-based company focused on defending critical services from cyberattack through Managed Detection and Response (MDR) and information security consulting. The company combines purpose-built technology with security analysts to deliver full-cycle threat detection, investigation, response, and recovery. CI targets critical systems in healthcare, the public sector, and other industries and offers assessment and testing services alongside its MDR platform. CI reported record-breaking Q1 sales that doubled its prior quarterly sales record, indicating strong sales velocity and momentum. The company was named an American Hospital Association preferred provider for MDR and its Critical Insight Healthcare Security Program. CI plans to use new funds to continue developing its vertical-specific cybersecurity and MDR platform and to support sales and marketing efforts. CI Security pairs monitoring and detection software with analysts who review and investigate attacks, focusing on healthcare and government customers. The company employs about 85 people and has offices in Seattle, Bremerton, and Ellensburg, Wash. It competes with larger security and tech firms such as ADT and Cisco Systems. Founded in 2012, the company changed its name from Critical Informatics to CI Security earlier this year. CI Security says its work helps healthcare customers reduce the risk of high-impact breaches and improve patient-focused security. Total funding to date is $22.4 million following the latest raise. CI Security operates the Critical Insight Managed Detection and Response (MDR) service, offering 24/7/365 monitoring and incident response for hospitals, clinics, cities, ports, and school districts. The company supports on-premises, AWS and Azure cloud, and Microsoft O365 environments, and its MDR is designed to spot attacks on IoT devices and defend operational technologies. CI Security emphasizes analyst-led investigations to reduce false positives and partner with customers during incidents, and it provides dedicated CI Success Engineers for each customer. It is expanding analyst capacity and capabilities through programs like PISCES and by sourcing talent from the military, technical colleges, and universities. The company operates two geographically diverse Security Operations Centers in Bremerton and Ellensburg, WA, has headquarters in Seattle, WA, and maintains offices across the United States. Financially, CI Security announced a $9.6 million Series B and has now raised over $16 million including a Series A in 2018. Critical Informatics provides Managed Detection and Response (MDR) services with specialized expertise in healthcare, financial services, and the public sector. Led by founder Michael Hamilton and CEO Garrett Silver, the company focuses on scaling MDR for large organizations. Its offerings include a core MDR service and a product called Continuous Vulnerability Investigation. The company plans to use recent capital to continue scaling MDR, accelerate product development, improve integrations with cloud services, and build customer-facing dashboards for both its core MDR service and Continuous Vulnerability Investigation. The raise completed an extension of the company’s original Series A and brought total funding to $6.35m. The company is based in Seattle, WA. Critical Informatics is a provider of managed cyber-security solutions based in Bremerton and Seattle, WA. The company delivers a managed cyber-security detection and response service to mid-sized organizations, particularly government agencies and healthcare and financial services companies. It closed a $3.25M Series A to support growth. The firm says it will use the funds to invest in product development, sales, and marketing. Leadership includes newly appointed CEO Garrett Silver, founder and Chief Information Security Officer Mike Hamilton, CTO Mike Simon, and Fred Langston, who heads consulting and professional services.

• eventcore

  Led · Equity · Feb 2018

  eventcore provides enterprise customers with technical solutions and professional services for event registration and platform tools. Its offerings are used by professional associations and multinational corporations for events ranging from 35 to more than 35,000 attendees. Led by CEO Mark Johnson and CTO Adrien Petersen, the company focuses on serving large-scale, complex events. eventcore completed a $4.1M growth capital financing to support its plans. The company intends to use the funds to expand sales and marketing on a national level and to accelerate product development. The financing and growth plans position eventcore to scale its enterprise sales and enhance its product platform.

No current team members are available.